Literature DB >> 10660728

[A summary report of response evaluation criteria in solid tumors (RECIST criteria)].

H Kusaba1, N Saijo.   

Abstract

The World Health Organization definitions for objective tumor response published in the 1979 WHO Handbook have been the most commonly used criteria around the world. However, some problems developed with the use of WHO criteria. These issues led to various modifications to the WHO criteria, resulting in a situation in which response criteria were no longer comparable among research organizations or researchers. However, because the efficacy of novel therapies and drugs is estimated according to tumor regression, it is very important to unify the definitions of objective tumor response. A revised version of the WHO criteria, Response Evaluation Criteria in Solid Tumors (RECIST criteria), was published in 1999 to deal with these issues. However, some problems concerning the evaluation of non-cytotoxic drugs and unidimensional measurements remain in the new criteria.

Entities:  

Mesh:

Year:  2000        PMID: 10660728

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  lncRNA HIT000218960 enhances resistance to 5-fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells.

Authors:  Li Bai; Kunbo Dong; Deyong Tong; Xiuna Shi; Sirong Wei; Yongguo Cai
Journal:  Exp Ther Med       Date:  2022-06-17       Impact factor: 2.751

2.  Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB-IIIB Cervical Cancer: A Retrospective Study at a Single Center.

Authors:  Meihua Xie; Xiuxiu Ding; Aiyu Chen; Huiqin Xiao; Xiaoye Wang; Youhong Wang; Huan Zhang
Journal:  Med Sci Monit       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.